GSK plc (GLAXF)
OTC
Real-time Data
01:30 PM
Day's Range
22.7352 wk Range
20.80Overview - GLAXF - GSK plc
Key Statistics
Valuation
Enterprise Value
148.90B
P/E (Trailing)
‪15.63‬
P/E (Forward)
‪11.08‬
PEG Ratio
‪-0.22‬
Price / Sales (TTM)
‪2.94‬
Price / Book
‪4.14‬
EV / EBITDA
‪10.39‬
Profitability
Gross Margin
‪73.05%‬
Profit Margin
‪14.52%‬
Operating Margin
‪30.94%‬
Return on Assets
‪10.00%‬
Return on Equity
‪33.38%‬
Ownership
Shares Outstanding
4.00B
Float
3.88B
Held by Insiders
‪1.74%‬
Held by Institutions
‪49.07%‬
Price stats
Beta
‪0.29‬
50-Day Avg
‪25.20‬
200-Day Avg
‪26.01‬
Dividends
Payout Ratio
‪56.88%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - GLAXF - GSK plc
Peers - GLAXF - GSK plc
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on OTC.
- GLAXFOTCGSK plc97.17BMarket Cap+20.46%52-week change15.63P/E (Trailing)‪14.52%‬Profit Margin
- RHHBFOTCRoche Holding AG364.91BMarket Cap+27.84%52-week change24.63P/E (Trailing)‪19.60%‬Profit Margin
- NVSEFOTCNovartis AG Registered Shares270.87BMarket Cap+11.61%52-week change21.26P/E (Trailing)‪22.50%‬Profit Margin
- NONOFOTCNovo Nordisk A/S171.32BMarket Cap-43.33%52-week change9.49P/E (Trailing)‪35.34%‬Profit Margin
- SNYNFOTCSanofi SA96.26BMarket Cap-30.80%52-week change21.31P/E (Trailing)‪8.09%‬Profit Margin
- CHGCYOTCChugai Pharmaceutical Co. Ltd.69.41BMarket Cap-1.33%52-week change23.18P/E (Trailing)‪35.10%‬Profit Margin
- BAYRYOTCBayer AG Sponsored ADR56.39BMarket Cap+43.65%52-week change28.38P/E (Trailing)‪-3.83%‬Profit Margin
Profile Summary - GLAXF - GSK plc
About
GSK plc is a British multinational pharmaceutical and biotechnology company headquartered in London, England. The company focuses on discovering, developing, and manufacturing prescription medicines and vaccines for a wide range of diseases. GSK plc operates as a focused biopharma business, with research and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
